硬膜下血肿中的PSMA摄取
一名81岁已知转移性前列腺癌伴近期生化进展的男性患者,接受18F-piflufolastat PSMA PET/CT再分期,CT显示左侧大脑凸面急性或慢性硬膜下血肿,PET显示血肿内相应放射性示踪剂活性。与2个月前头部CT相比血肿显著增大,患者转诊至附近急诊科行重复影像和硬膜下引流,术后因硬膜下血液产物快速再积聚死亡。
要点
- PSMA PET/CT再分期中可见硬膜下血肿内放射性示踪剂摄取。
- 与2个月前头部CT相比,该硬膜下血肿显著增大。
- 患者行硬膜下引流后因血液产物快速再积聚死亡。
核心结论
- 硬膜下血肿可显示PSMA放射性示踪剂摄取,在PSMA PET/CT判读时应予以注意。
研究设计与样本
- 病例报告:一名81岁已知转移性前列腺癌伴近期生化进展的男性患者,接受18F-piflufolastat PSMA PET/CT再分期。
主要发现
- CT显示左侧大脑凸面急性或慢性硬膜下血肿,PET显示血肿内相应放射性示踪剂活性。
- 与2个月前头部CT相比,该硬膜下血肿显著增大。
- 患者转诊至附近急诊科行重复影像和硬膜下引流,术后因硬膜下血液产物快速再积聚死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An 81-year-old man with known metastatic prostate cancer with recent biochemical progression underwent a PSMA PET/CT ( 18 F-piflufolastat) for restaging. Review of the images demonstrated an acute or chronic left cerebral convexity subdural hematoma on CT with corresponding radiotracer activity throughout the collection on PET. Analysis of the patient's prior imaging showed that this subdural hematoma had significantly increased in size when compared with a head CT obtained 2 months prior. The patient was referred to a nearby emergency department and underwent repeat imaging and subdural drain placement. Unfortunately, the patient died secondary to rapid reaccumulation of subdural blood products after intervention.
引用
- Lawson TR, O'Brien SR, Pantel AR, et al. PSMA Uptake in a Subdural Hematoma. Clin Nucl Med. 2023. PMID: 37486315. doi:10.1097/RLU.0000000000004777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。